Tag: FR0010557264

news source FOR company information content 1 market releases

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE

AB Science : Le masitinib reçoit l’autorisation de la FDA et de l’EMA pour l’etude confirmatoire de phase 3 dans le cancer de la...

COMMUNIQUÉ DE PRESSE

AB Science announces EMA approval of Masivet shelf-life extension to 4 years

PRESS RELEASE

AB Science annonce l’approbation par l’EMA de la prolongation de la durée de conservation de Masivet à 4 ans

COMMUNIQUE DE PRESSE

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsFR0010557264